Case ReportInternational Journal of Basic & Clinical Pharmacology

Publication:
Acute ST-elevation myocardial infraction after use of oral sumatriptan: a rare presentation

Int J Basic Clin Pharmacol. 2020;9(11):1746-1748.DOI10.18203/2319-2003.ijbcp20204506

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Sumatriptan is an agonist of 5-hydroxytryptamine type-1 (5HT1) receptors that is widely used as a migraine abortant; however, there have been studies showing angina, coronary vasospasm, and even myocardial infraction in patients with predisposing cardiac risk factors. We present the case of a female patient with no cardiovascular risk factor who developed ST-elevation myocardial infraction 30 minutes after ingesting oral sumatriptan for her migraine.

Keywords

Affiliations

  1. Medical Officer, CHC, Laxmangarh, Sikar, Rajasthan, India
  2. Department of Cardiology, Noble Care Hospital, Sikar, Rajasthan, India

Full item record